Skip to main content
Top
Published in: BMC Pediatrics 1/2022

Open Access 01-12-2022 | Autism Spectrum Disorder | Research

Vitamin/mineral/micronutrient supplement for autism spectrum disorders: a research survey

Authors: James B. Adams, Jasmine Kirby, Tapan Audhya, Paul Whiteley, Jaclyn Bain

Published in: BMC Pediatrics | Issue 1/2022

Login to get access

Abstract

Background

Vitamin and mineral supplements are widely used by children and adults diagnosed with autism spectrum disorder (ASD). Several studies have reported benefits of such supplements in resolving nutritional deficiencies, treating various metabolic problems and improving symptoms and overall quality of life.

Methods

This research survey collected evaluations from 161 people about the effectiveness of ANRC-Essentials Plus (ANRC-EP), a vitamin/mineral/micronutrient supplement designed for children and adults with autism. Although this was an open-label survey, results were compared with a three-month randomized double-blind placebo-controlled study of an earlier version of the supplement. Evaluations included the Parent Global Impressions of Autism (PGIA) and the Overall Benefit/Adverse Effect scale of the National Survey on Treatment Effectiveness for Autism (NSTEA).

Results

The participants reported substantially higher Average PGIA Scores than the placebo group in a similar previous study, with an estimated effect size of 0.66. Based on the NSTEA questionnaire, 73% of participants rated the Overall Benefit as Moderate, Good, or Great, with scores that were substantially higher than the NSTEA study found for multi-vitamins, the average of 58 nutraceuticals, and the average of 28 psychiatric and seizure medications. The Overall Adverse Effect score was low (0.25/3.0), similar or slightly higher than other nutraceuticals, and much lower than the average of 28 psychiatric and seizure medications (0.9/3.0). Sub-analysis found that the Overall Benefit of ANRC-EP was not significantly affected by gender, age, autism severity, diet quality, self-limited diet, use of psychiatric or seizure medications, dosage, developmental history, intellectual disability, or seizures. This indicates that ANRC-EP may be beneficial for a wide range of children and adults with ASD.
A limitation of this study is the retrospective nature of the survey, and that participants who had good benefits were more likely to respond.

Conclusions

This study found that ANRC-EP had significant benefits for a wide range of symptoms, and low adverse effects.
Literature
3.
go back to reference Kirby AV, Bilder DA, Wiggins LD, Hughes MM, Davis J, Hall-Lande JA, Lee LC, McMahon WM, Bakian AV. Sensory features in autism: findings from a large population-based surveillance system. Autism Res. 2022. https://doi.org/10.1002/aur.2670. Epub ahead of print. PMID: 35040592. Kirby AV, Bilder DA, Wiggins LD, Hughes MM, Davis J, Hall-Lande JA, Lee LC, McMahon WM, Bakian AV. Sensory features in autism: findings from a large population-based surveillance system. Autism Res. 2022. https://​doi.​org/​10.​1002/​aur.​2670. Epub ahead of print. PMID: 35040592.
14.
go back to reference Javadfar Z, Abdollahzad H, Moludi J, Rezaeian S, Amirian H, Foroughi AA, Nachvak SM, Goharmehr N, Mostafai R. Effects of vitamin D supplementation on core symptoms, serum serotonin, and interleukin-6 in children with autism spectrum disorders: a randomized clinical trial. Nutrition. 2020;79–80:110986. https://doi.org/10.1016/j.nut.2020.110986 (Epub 2020 Aug 28 PMID: 32966919).CrossRefPubMed Javadfar Z, Abdollahzad H, Moludi J, Rezaeian S, Amirian H, Foroughi AA, Nachvak SM, Goharmehr N, Mostafai R. Effects of vitamin D supplementation on core symptoms, serum serotonin, and interleukin-6 in children with autism spectrum disorders: a randomized clinical trial. Nutrition. 2020;79–80:110986. https://​doi.​org/​10.​1016/​j.​nut.​2020.​110986 (Epub 2020 Aug 28 PMID: 32966919).CrossRefPubMed
18.
go back to reference Li M, Francis E, Hinkle SN, Ajjarapu AS, Zhang C. Preconception and prenatal nutrition and neurodevelopmental disorders: a systematic review and meta-analysis. Nutrients. 2019;11(7):1628. Li M, Francis E, Hinkle SN, Ajjarapu AS, Zhang C. Preconception and prenatal nutrition and neurodevelopmental disorders: a systematic review and meta-analysis. Nutrients. 2019;11(7):1628.
19.
go back to reference Raghavan R, Riley AW, Volk H, Caruso D, Hironaka L, Sices L, et al. Maternal multivitamin intake, plasma folate and vitamin B(12) levels and autism spectrum disorder risk in offspring. Paediatr Perinat Epidemiol. 2018;32(1):100–11.CrossRef Raghavan R, Riley AW, Volk H, Caruso D, Hironaka L, Sices L, et al. Maternal multivitamin intake, plasma folate and vitamin B(12) levels and autism spectrum disorder risk in offspring. Paediatr Perinat Epidemiol. 2018;32(1):100–11.CrossRef
20.
go back to reference Raghavan R, Selhub J, Paul L, Ji Y, Wang G, Hong X, et al. A prospective birth cohort study on cord blood folate subtypes and risk of autism spectrum disorder. Am J Clin Nutr. 2020;112(5):1304–17.CrossRef Raghavan R, Selhub J, Paul L, Ji Y, Wang G, Hong X, et al. A prospective birth cohort study on cord blood folate subtypes and risk of autism spectrum disorder. Am J Clin Nutr. 2020;112(5):1304–17.CrossRef
22.
go back to reference Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr. 2011;12(11):111. https://doi.org/10.1186/1471-2431-11-111 (PMID:22151477;PMCID:PMC3266205).CrossRef Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr. 2011;12(11):111. https://​doi.​org/​10.​1186/​1471-2431-11-111 (PMID:22151477;PMCID:PMC3266205).CrossRef
26.
go back to reference James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, Hubanks A, Gaylor DW. Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr. 2009;89:425–30.CrossRef James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, Hubanks A, Gaylor DW. Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr. 2009;89:425–30.CrossRef
27.
go back to reference Frye RE, Slattery J, Delhey L, Furgerson B, Strickland T, Tippett M, Sailey A, Wynne R, Rose S, Melnyk S, Jill James S, Sequeira JM, Quadros EV. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. 2018;23(2):247–56. https://doi.org/10.1038/mp.2016.168 (Epub 2016 Oct 18. PMID: 27752075; PMCID: PMC5794882).CrossRefPubMed Frye RE, Slattery J, Delhey L, Furgerson B, Strickland T, Tippett M, Sailey A, Wynne R, Rose S, Melnyk S, Jill James S, Sequeira JM, Quadros EV. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. 2018;23(2):247–56. https://​doi.​org/​10.​1038/​mp.​2016.​168 (Epub 2016 Oct 18. PMID: 27752075; PMCID: PMC5794882).CrossRefPubMed
28.
go back to reference Batebi N, Moghaddam HS, Hasanzadeh A, Fakour Y, Mohammadi MR, Akhondzadeh S. Folinic acid as adjunctive therapy in treatment of inappropriate speech in children with autism: a double-blind and placebo-controlled randomized trial. Child Psychiatry Hum Dev. 2021;52(5):928–38. https://doi.org/10.1007/s10578-020-01072-8 (Epub 2020 Oct 7 PMID: 33029705).CrossRefPubMed Batebi N, Moghaddam HS, Hasanzadeh A, Fakour Y, Mohammadi MR, Akhondzadeh S. Folinic acid as adjunctive therapy in treatment of inappropriate speech in children with autism: a double-blind and placebo-controlled randomized trial. Child Psychiatry Hum Dev. 2021;52(5):928–38. https://​doi.​org/​10.​1007/​s10578-020-01072-8 (Epub 2020 Oct 7 PMID: 33029705).CrossRefPubMed
30.
31.
go back to reference Song L, Luo X, Jiang Q, Chen Z, Zhou L, Wang D, Chen A. Vitamin D supplementation is beneficial for children with autism spectrum disorder: a meta-analysis. Clin Psychopharmacol Neurosci. 2020;18:203–13.CrossRef Song L, Luo X, Jiang Q, Chen Z, Zhou L, Wang D, Chen A. Vitamin D supplementation is beneficial for children with autism spectrum disorder: a meta-analysis. Clin Psychopharmacol Neurosci. 2020;18:203–13.CrossRef
33.
go back to reference Geier DA, Kern JK, Davis G, King PG, Adams JB, Young JL, Geier MR. A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Med Sci Monit. 2011;17:PI15–23.CrossRef Geier DA, Kern JK, Davis G, King PG, Adams JB, Young JL, Geier MR. A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Med Sci Monit. 2011;17:PI15–23.CrossRef
34.
go back to reference Fahmy SF, El-hamamsy MH, Zaki OK, Badary OA. L-Carnitine supplementation improves the behavioral symptoms in autistic children. Res Autism Spectr Disord. 2013;7:159–66.CrossRef Fahmy SF, El-hamamsy MH, Zaki OK, Badary OA. L-Carnitine supplementation improves the behavioral symptoms in autistic children. Res Autism Spectr Disord. 2013;7:159–66.CrossRef
38.
go back to reference Benke PJ, Duchowny M, McKnight D. Biotin and acetazolamide for treatment of an unusual child with autism plus lack of nail and hair growth. Pediatr Neurol. 2018;79:61–4.CrossRef Benke PJ, Duchowny M, McKnight D. Biotin and acetazolamide for treatment of an unusual child with autism plus lack of nail and hair growth. Pediatr Neurol. 2018;79:61–4.CrossRef
Metadata
Title
Vitamin/mineral/micronutrient supplement for autism spectrum disorders: a research survey
Authors
James B. Adams
Jasmine Kirby
Tapan Audhya
Paul Whiteley
Jaclyn Bain
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2022
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-022-03628-0

Other articles of this Issue 1/2022

BMC Pediatrics 1/2022 Go to the issue